Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
U.S. FDA: Second Look Digital can be packaged with MAMMOMAT NovationDR
July 24th, 2005
iCAD, Inc., (ICAD), a provider of computer-aided detection (CAD) solutions for the early identification of cancer, announced that the United States Food and Drug Administration (FDA) has permitted iCAD to package its Second Look Digital offering with Siemens Medical Solutions MAMMOMAT NovationDR Full-Field Digital System. The joint solution combines hardware from Siemens with iCAD's digital technology and patented algorithms to help doctors and radiologists better detect cancer during a full-field digital mammography exam. With multiple operating points and viewing flexibility, the digital CAD solution automatically identifies and marks regions commonly associated with...
Source: Medical Letter on the CDC & FDA (2005-07-24)
|
